The health ministry has suggested that the pricing of essential medicines be based on either the average price of the three cheapest brands or the government's bulk procurement price, rejecting a draft policy of the department of pharmaceuticals. The ministry's recommendation, made earlier this month, has drawn flak from drug manufacturers who say it can wipe out a third of country's Rs 60,000-crore drugs market. "It will have a crippling effect and erode at least one-third of the market," Ameesh Masurekar, director of drug market research firm AIOCD Pharmasofttech AWACS, told ET.
Source: Economic Times
No comments:
Post a Comment